Orchid Pharma Limited Share Price Bombay S.E.
Equities
524372
INE191A01019
Pharmaceuticals
Sales 2024 | 8.19B 98.09M 7.73B | Sales 2025 * | 10.28B 123M 9.71B | Capitalization | 53.65B 642M 50.64B |
---|---|---|---|---|---|
Net income 2024 | 922M 11.04M 870M | Net income 2025 * | 1.49B 17.79M 1.4B | EV / Sales 2024 | 6.31 x |
Net cash position 2024 | 1.32B 15.81M 1.25B | Net cash position 2025 * | 1.65B 19.73M 1.56B | EV / Sales 2025 * | 5.06 x |
P/E ratio 2024 |
72.1
x | P/E ratio 2025 * |
35.9
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.03% |
Latest transcript on Orchid Pharma Limited
Managers | Title | Age | Since |
---|---|---|---|
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 30/03/20 |
Director of Finance/CFO | - | 28/06/20 | |
Kapil Dayya
CMP | Compliance Officer | - | 12-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 30/03/20 | |
Mridul Dhanuka
BRD | Director/Board Member | 42 | 30/03/20 |
Manish Dhanuka
CEO | Chief Executive Officer | 56 | 30/03/20 |
1st Jan change | Capi. | |
---|---|---|
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |